Home < About us < History
 
  Establishment of Neurotech Pharmaceuticals
G7 Project Award from the Ministry of Science & Technology
   : Development of Alzheimer’s Disease models and Neuroprotectant compounds
  Venture Business Acknowledgement (Small and Medium Business Administration)
  Development of new drug candidate, Neu2000
  Completion of efficacy study in stroke, Neu2000
National Lab Acknowledgement (Korea Industrial Technology Association)
  Patent registered : Brain Cell Protection, BAS derivatives
Out-license of Neu2000 for Korea : Choongwae Pharma
  Patent registered in U.S. for Neu2000
Initiation of Neu2000 pre-clinical studies in the U.S.
21 C Frontier Project Award from the Ministry of Science & Technology
    : Development for an Anti-Alzheimer’s Drug
  Establishment of US Subsidiary, AmKor Pharma (Seattle, WA)
Patent registered in Europe for Neu2000
Development of new drug candidate, AAD-2004
   : Anti-Alzheimer’s Drug
Validation through efficacy studies in Glaucoma, Neu2000
Awarded the Driving Force Project for the Next Generation from Gyeonggi Provincial Government
    : Development of a New Drug in spinal cord injury and ALS
  National R&D project, AAD-2004 (Ministry of Health & Welfare)
Completion of efficacy study in spinal code injury, Neu2000
  M&A with EOLITH Co. (a Kosdaq listed company)
National R&D Project Award from the Ministry of Health & Welfare
   : Development of AAD-2004 as an Anti-Alzheimer’s Drug
Frontier Project Award from the Ministry of Science & Technology
   : Development of NP-07 for pain
Initiation of Neu2000 clinical phase I study in the U.S.
 
Untitled Document